Individual #00416883

ID_report 1
Reference PubMed: Munier 2019
Remarks -
Gender M
Consanguinity -
Country -
Population -
Age at death -
VIP -
Data_av -
Treatment 23-gauge pars plana vitrectomy with associated encircling buckle
Panel size 1
Diseases EVR4
Owner name LOVD
Database submission license Creative Commons Attribution 4.0 InternationalCreative Commons License
Created by Anna Tracewska
Date created 2022-09-09 11:38:01 +02:00 (CEST)
Date last edited N/A


Phenotypes

vitreoretinopathy, exudative, type 4 (EVR4) (EVR4)   Add phenotype for this disease

AscendingPhenotype ID     

Phenotype details     

Diagnosis/Initial     

Diagnosis/Definite     

Inheritance     

Age/Examination     

Age/Diagnosis     

Age/Onset     

Phenotype/Onset     

Protein     

Owner     
0000308395 total tractional retinal detachment requiring multiple vitreoretinal surgeries in his right eye; last-recorded visual acuity 3 months earlier, right/left eye: 20/100, 20/50; ophthalmological examination at 17y: a decrease in visual acuity in his left eye to 20/63; fundus: temporal dragging of retinal vessels, peripheral exudation, and vitreoretinal tractions without retinal detachment; spectral-domain optical coherence tomography: vitreomacular traction with intraretinal cysts; central macular thickness: 283 um; re-evaluation 15 days later: progression to a lamellar macular hole; surgical procedure was suggested, 1 week later (before the surgery could be performed) acute metamorphopsia, visual acuity drop to 20/200; spectral-domain optical coherence tomography: full-thickness macular hole. Surgical management by 23-gauge pars plana vitrectomy with associated encircling buckle; posterior vitreous detachment was induced, internal limiting membrane peeled after staining with brilliant blue G, and SF6 was used as gas tamponade; 3 months postoperatively, visual acuity: 20/25. spectral-domain optical coherence tomography: sustained closure of the macular hole, with associated thinning of the neurosensory retina (central macular thickness: 166 um) - familial exudative vitreoretinopathy Isolated (sporadic) 17y 13y - - - LOVD



Screenings


AscendingScreening ID     

Template     

Technique     

Tissue     

Remarks     

Genes screened     

Variants found     

Owner     
0000418166 DNA SEQ blood - LRP5 3 LOVD



Variants

3 entries on 1 page. Showing entries 1 - 3.
Legend   How to query  

Chr     

Allele     

Effect     

Classification method     

Clinical classification     

AscendingDNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Owner     

Gene     

IDbase Accession Number     

VariO/DNA     

VariO/Protein     

VariO/RNA     

Exon     

DNA change (cDNA)     

Haplotype     

RNA change     

Protein     

P-domain     

Exon_old     

Function/GVS     

Predict/AGVGD     

Predict/MutationTaster     

Predict/SIFT     

Predicted     

Type/DNA     

CpG     

Enzyme activity     

mRNA level     

Predict-BioInf     

Legacy protein change     

Protein level     
11 Parent #1 +?/. - likely pathogenic g.68153909G>A g.68386441G>A LRP5 p.[D381N] - LRP5_000260 heterozygous PubMed: Munier 2019 - - Germline/De novo (untested) yes - - - - LOVD LRP5 - - - - - NM_002335.4:c.1141G>A - r.(?) p.(Asp381Asn) - - - - - - - - - - - - - -
11 Parent #2 +?/. - likely pathogenic g.68201295C>T g.68433827C>T LRP5 p.[A1330V;D1356N] - LRP5_000040 heterozygous PubMed: Munier 2019 - - Germline/De novo (untested) yes - - - - LOVD LRP5 - - - - - NM_002335.4:c.3989C>T - r.(?) p.(Ala1330Val) - - - - - - - - - - - - - -
11 Parent #2 +?/. - likely pathogenic g.68204422G>A g.68436954G>A LRP5 p.[A1330V;D1356N] - LRP5_000432 heterozygous PubMed: Munier 2019 - - Germline/De novo (untested) yes - - - - LOVD LRP5 - - - - - NM_002335.4:c.4066G>A - r.(?) p.(Asp1356Asn) - - - - - - - - - - - - - -
Legend   How to query  


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.